DETERMINATION OF ORALLY COADMINISTERED NADOLOL AND ITS DEUTERATED ANALOG IN HUMAN-SERUM AND URINE BY GAS-CHROMATOGRAPHY WITH SELECTED-ION MONITORING MASS-SPECTROMETRY

被引：7

作者：

COHEN, AI

DEVLIN, RG

IVASHKIV, E

FUNKE, PT

MCCORMICK, T

机构：

[1] SQUIBB INST MED RES,DEPT CLIN PHARMACOL,NEW BRUNSWICK,NJ 08903

[2] SQUIBB INST MED RES,PRINCETON,NJ 08540

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1984年 / 73卷 / 11期

关键词：

D O I：

10.1002/jps.2600731121

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1571 / 1575

页数：5

共 18 条

[1] BIOAVAILABILITY AND KINETICS OF MAPROTILINE [J].

ALKALAY, D ;

WAGNER, WE ;

CARLSEN, S ;

KHEMANI, L ;

VOLK, J ;

BARTLETT, MF ;

LESHER, A .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) :697-703

[2]

BLANFORD MF, 1980, DRUG INTEL CLIN PHAR, V14, P825

[3] CAPILLARY COLUMN GLC-MASS SPECTROMETRIC ASSAY WITH SELECTED-ION MONITORING FOR TIMOLOL AND [13C3]TIMOLOL IN HUMAN-PLASMA [J].

CARLIN, JR ;

WALKER, RW ;

DAVIES, RO ;

FERGUSON, RT ;

VANDENHEUVEL, WJA .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (10) :1111-1115

[4] DETERMINATION OF CAPTOPRIL IN HUMAN-BLOOD AND URINE BY GLC-SELECTED ION MONITORING MASS-SPECTROMETRY AFTER ORAL COADMINISTRATION WITH ITS ISOTOPOMER [J].

COHEN, AI ;

DEVLIN, RG ;

IVASHKIV, E ;

FUNKE, PT ;

MCCORMICK, T .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (11) :1251-1256

[5] NONDEPRESSANT BETA-ADRENERGIC BLOCKING-AGENTS .1. SUBSTITUTED 3-AMINO-1-(5,6,7,8-TETRAHYDRO-1-NAPHTHOXY)-2-PROPANOLS [J].

CONDON, ME ;

CIMARUSTI, CM ;

FOX, R ;

NARAYANAN, VL ;

REID, J ;

SUNDEEN, JE ;

HAUCK, FP .

JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (09) :913-922

[6] METABOLIC STUDIES IN PATIENTS WITH NADOLOL - ORAL AND INTRAVENOUS ADMINISTRATION [J].

DREYFUSS, J ;

BRANNICK, LJ ;

VUKOVICH, RA ;

SHAW, JM ;

WILLARD, DA .

JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (5-6) :300-307

[7] PHARMACOKINETICS OF NADOLOL, A BETA-RECEPTOR ANTAGONIST - ADMINISTRATION OF THERAPEUTIC SINGLE-DOSAGE AND MULTIPLE-DOSAGE REGIMENS TO HYPERTENSIVE PATIENTS [J].

DREYFUSS, J ;

GRIFFITH, DL ;

SINGHVI, SM ;

SHAW, JM ;

ROSS, JJ ;

VUKOVICH, RA ;

WILLARD, DA .

JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 19 (11-1) :712-720

[8] DETERMINATION OF SERUM NADOLOL LEVELS BY GLC-SELECTED ION MONITORING MASS-SPECTROMETRY - COMPARISON WITH A SPECTROFLUOROMETRIC METHOD [J].

FUNKE, PT ;

MALLEY, MF ;

IVASHKIV, E ;

COHEN, AI .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (05) :653-657

[9] BIOAVAILABILITY OF IMIPRAMINE TABLETS RELATIVE TO A STABLE ISOTOPE-LABELED INTERNAL STANDARD - INCREASING THE POWER OF BIOAVAILABILITY TESTS [J].

HECK, HDA ;

BUTTRILL, SE ;

FLYNN, NW ;

DYER, RL ;

ANBAR, M ;

CAIRNS, T ;

DIGHE, S ;

CABANA, BE .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (03) :233-248

[10] NADOLOL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN HYPERTENSION AND ANGINA-PECTORIS [J].

HEEL, RC ;

BROGDEN, RN ;

PAKES, GE ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1980, 20 (01) :1-23

← 1 2 →